MAPT and Alzheimer disease: Copper modulation by treating a double transgenic AD mouse model with CuII(gtsm), a bis(thiosemicarbazone) or PBT2, a copper/zinc ionophore, improved tau phosphorylation, Aβ oligomerization and cognition (Adlard et al., 2008; Crouch et al., 2009).